Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
- COVID-19 (76)
- Advertising (65)
- COVID-19 vaccines (30)
- Medicine safety (27)
- Regulatory compliance (17)
- Labelling and packaging (8)
- Legislation (8)
- Listed medicines (8)
- Non-prescription medicines (8)
- Prescription medicines (8)
- Therapeutic goods regulation (8)
- Vaping hub (8)
- Assessed listed medicines (6)
- Complementary medicines (4)
- Safety (4)
- Manufacturing (3)
- Medical devices safety (3)
- Medicinal cannabis hub (3)
- Over the counter (OTC) medicines (3)
- Alert/Advisory (2)
- In Vitro Diagnostic medical devices (IVDs) (2)
- Scheduling (national classification system) (2)
- Advisory bodies and committees (1)
- Australian Register of Therapeutic Goods (ARTG) (1)
- Blood safety (1)
- Compliance and enforcement hub (1)
- Import and export (1)
- Shortages (1)
- Sunscreens (1)
- Travelling with health products (1)
- Weight loss products (1)
Search
209 result(s) found, displaying 151 to 175
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
Media releasesThe TGA has issued an infringement notice for $13,320 to Vaxine Pty Ltd of Adelaide for advertising an unapproved COVID-19 vaccine in alleged breach of the Therapeutic Goods Act 1989.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
Media releasesTGA, part of the Department of Health, has granted a second provisional determination to Biocelect Pty Ltd (on behalf of Novavax Inc.) in relation to its COVID-19 vaccine, Nuvaxovid.
-
Media releasesThe TGA has issued an infringement notice of $13,320 to Getafix Café Pty Ltd (the company) for an alleged breach of the Therapeutic Goods Act 1989 in relation to the advertising of a COVID-19 rapid antigen test on its website.
-
Media releasesGold Coast company FuturePro Pty Ltd, trading as Inet Herbal, has pleaded guilty to seven breaches of the Therapeutic Goods Act 1989.
-
Media releasesThe TGA has issued two infringement notices totalling $26,640 to DPD Stores Pty Ltd, trading as Lanyon Newsagency in the ACT, in relation to alleged unlawful supply of nicotine vaping products.
-
Media releasesThe TGA has issued an infringement notice for $7,992 to a Melbourne based Pharmacist for the alleged unlawful advertising of nicotine vaping products.
-
Media releasesThe TGA is urging consumers to only purchase COVID-19 rapid antigen tests (RATs) that are approved for use in Australia to avoid the risk of poor test performance that could arise from using unapproved, repackaged or repurposed RATs.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
Media releasesThe TGA has issued two infringement notices totalling $26,640 to a Sydney-based company for alleged unlawful advertising of a TENS device.
-
Media releasesConsumers are advised to be cautious about ivermectin products that are sold by unverified online stores.
-
MEPH Pharmacy Pty Ltd fined $39,960 for the alleged unlawful advertising of nicotine vaping products
Media releasesMEPH Pharmacy Pty Ltd fined $39,960 for the alleged unlawful advertising of nicotine vaping products -
Media releasesThe TGA has issued an infringement notice for $2,664 to an individual for a NSW based herbal medicine practitioner for an alleged breach of the Advertising Code.
-
NoticesA new Therapeutic Goods Determination for listed medicine ingredients commences on 1 March 2022.
-
Safety updatesMedicines Safety Update - Information for health professionals
-
NoticesThis labelling exemption is granted under section 1.5.5 of Part 2 of the current Poisons Standard.
-
Media releasesThe TGA has granted provisional approval to AstraZeneca Pty Ltd for its tixagevimab and cilgavimab (EVUSHELD) for the prevention of COVID-19 in people who are at risk of infection but have not been exposed to the virus, known as pre-exposure prevention of COVID-19.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
Safety updatesMedicines safety update - important information for health professionals
-
NewsThe TGA has granted provisional approval to AstraZeneca Pty Ltd for its tixagevimab and cilgavimab (EVUSHELD) for the treatment and prevention of COVID-19 in people who are at risk of infection but have not been exposed to the virus, known as pre-exposure prevention of COVID-19.
-
Melbourne-based individual fined $5,328 for alleged unlawful importation of nicotine vaping products
Media releasesThe TGA has issued two infringement notices totalling $5,328 to a Melbourne-based individual for alleged unlawful importation of nicotine vaping products.